However, as stated earlier, methemoglobinemia has a wide range of symptomology and, especially for those burdened by metastatic cancer, intensive VEGF therapy and other hematologic disorders, this symptom threshold could be significantly lower for complex oncology patients. The gene discussed is VEGFA; the disease is hematologic disorder.